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Ubiquitin sets the aging timer 
The maintenance of protein homeostasis, or proteostasis, involves the degradation of 
misfolded and damaged proteins and is essential for cellular function, organismal growth, 
and ultimately viability. The integrity of the proteome is a long-term challenge not only for 
individual cells but also for entire organisms since damaged and aggregated proteins 
accumulate with stress and aging. The ubiquitin/proteasome system (UPS) and 
autophagy are the major proteolytic routes embedded in a cellular quality control network 
that ensure efficient turnover of defective proteins. Both pathways are initiated by 
ubiquitylation, which provides the recognition signal for substrate selection. The 
ubiquitylation step is mediated by an enzymatic cascade that involves ubiquitin-activating 
enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin protein ligases (E3), 
whereas deubiquitylation enzymes (DUBs) reverse this modification by removing the 
ubiquitin moieties1. 
It is commonly thought that an age-related impairment of ubiquitin dependent 
proteolysis correlates with enhanced accumulation of damaged proteins, which can be 
cytotoxic and shorten lifespan. Beside the requirement of proteasomal integrity for normal 
lifespan, the identification of ubiquitin-dependent degradation pathways that specifically 
control the stability of lifespan regulators further represents a key role of the UPS in the 
aging process. Initial results provide evidence that autophagy can act as a compensatory 
degradation system when the UPS is impaired. However, the impact of stress and aging-
induced signals on the fine-tuning of ubiquitin-dependent proteolytic pathways remains to 
be explored. 
 
Age-related decline in UPS function 
Cellular differentiation, developmental processes, and environmental factors challenge 
the integrity of the proteome in every eukaryotic cell. Accumulation of damaged and 
aggregated proteins is often associated with neurodegenerative disorders including 
Alzheimer’s and Parkinson’s diseases. Recent studies provide evidence that especially 
the progressive decline in UPS function contributes to enhanced protein aggregation and 
normal aging2. Initial works focused on the proteasome assembly chaperone Ump1 or 
the 19S subunit Rpn11 identified that both synthesis and assembly of the 26S 
proteasome is required to maintain viability in yeast models of aging3. Aging is associated 
with the accumulation of ubiquitylated protein aggregates, which have been shown to 
inhibit the activity of the 26S proteasome4. Thus, compromised cellular clearance of 
damaged proteins during aging could further aggravate the proteotoxic effect and thus 
reinforce the aging process. Given its functional impairment in aging, increased ubiquitin-
dependent proteolysis might have beneficial effects on longevity. Indeed, elevated 
proteasomal capacity extends the replicative lifespan of budding yeast5, and the 
activation of the UPS extends longevity in multicellular organisms. Overexpression of the 
19S subunit RPN-6 or a key regulator of ubiquitin-dependent degradation, Ubiquilin, 
increases the lifespan and delays the onset of protein aggregate formation in both 
Caenorhabditis elegans and mice6,7. Conversely, inactivation of the ubiquitin activating 
enzyme (E1) Uba1 reduces the adult lifespan of Drosophila, reflecting the intricate 
balance between ubiquitylation and longevity8. 
The spatial organization of cellular processes in eukaryotes led to the evolvement 
of organelle specific protein degradation pathways. For example, the turnover of 
misfolded proteins that accumulate in the endoplasmic reticulum (ER) involves the 
retrotranslocation into the cytosol for ubiquitylation, and proteasomal targeting through a 
process called ER-associated degradation (ERAD). Decreased expression of ERAD 
factors shortens the lifespan of worms9, suggesting that protein quality assurance in the 
ER has substantial effects on organismal homeostasis and aging. Similar to ERAD, the 
degradation of mitochondrial proteins is also mediated by the UPS through the 
mitochondria-associated degradation (MAD) pathway10. Maintenance of mitochondrial 
proteostasis is especially important in cellular homeostasis because damaged 
mitochondria produce excessive amounts of reactive oxygen species that are cytotoxic. 
Age-associated impairment in mitochondrial metabolism causes increased protein 
oxidation, which can either overload the degradation capacity of the 26S proteasome or 
directly damage its subunits (Fig. 1). Therefore, sustained proteasomal inhibition by ROS 
could dramatically reduce ubiquitin-mediated turnover and further aggravate proteostasis 
decline11. Protein folding stress in the ER or in mitochondria induces transcriptional 
programs called the unfolded protein response (UPRER or UPRmt), which enhance the 
chaperone network and boost the degradation of misfolded proteins12. The activation of 
the UPRER, possibly involving the enhancement of ubiquitin-dependent proteolytic 
pathways, has recently been shown to increase the lifespan of yeast and C. elegans13,14. 
Consequently, the coordination of different proteolytic pathways is essential in 
maintaining cellular homeostasis. There is a growing interest in the use of chemical 
interventions that aim to preserve a youthful cellular state. The observation that 
rapamycin treatment delays multiple aspects of aging in different organisms by induction 
of autophagy has opened new paths to explore. Similarly, the identification of new drugs 
modulating the activity of the UPS would be extremely beneficial to develop therapeutic 
strategies to improve cellular proteostasis in age-related diseases. 
 
Ubiquitin-dependent regulation of longevity  
Aging is characterized by a general functional decline of cells with increased risk of 
disease. It is driven by stochastic accumulation of damage in biomolecules, nevertheless 
the functional decline is strongly influenced by genetic factors as well. The best 
characterized evolutionarily conserved regulatory pathways of aging are the nutrient 
sensing insulin/insulin-like growth factor 1 (IGF-1) signaling (IIS), the mitochondrial 
respiration, the caloric restriction (CR) and the germline mediated longevity15. 
Interestingly, several of these longevity pathways support cellular proteostasis by 
transcriptional upregulation of UPS components. Recent studies provide an intriguing 
concept defining how IIS modulates proteasomal degradation according to spatial and 
temporal proteolytic demands in different organisms. Reduced insulin signaling extends 
lifespan from yeast to mammals, which is performed by the activation of multiple 
transcription factors (Fig. 1). IIS regulates the expression of the proteasome-associated 
DUB UBH-4/Uchl5 that normally functions as a tissue-specific inhibitor of the 26S 
proteasome16. This effect is mediated by the C. elegans FoxO transcription factor DAF-
16. On the other hand, the transcription factor SKN-1/Nrf2 initiates the expression of 
multiple proteasomal subunit genes upon proteotoxic or oxidative stress, which causes 
increased capacity of the 26S proteasome in worms, flies, and mammals17. 
Whereas a general decline of ubiquitin-dependent proteolysis contributes to aging, 
several studies provide evidence that direct ubiquitylation of distinct lifespan regulators 
also actively influences the life expectancy of different organisms. In fact, the UPS 
regulates multiple steps of IIS, affecting the stability or localization of almost all signaling 
components (Fig. 1). The insulin receptor, the insulin receptor substrate, the AKT kinases, 
the negative regulator PTEN phosphatase and the FoxO transcription factors were all 
shown to be targets for ubiquitylation by different E3 ligases, including CHIP, Mdm2, and 
Nedd418. In mammalian cells FoxO1 ubiquitylation is regulated by Skp2-SCF and COP1. 
The E3 ligase MDM2 mediates ubiquitin-dependent degradation of FoxO1 and FoxO3A 
in response to stress. In contrast, monoubiquitylation of FoxO4 by MDM2 drives its 
nuclear localization and activation, which is reversed by the DUB USP7. A fine tuned 
balance between ubiquitylation and deubiquitylation, governed by the ubiquitin-selective 
chaperone CDC-48 and the deubiquitylation enzyme ATX-3 has recently been shown to 
regulate IIS in worms. The close interplay between both factors determines the topology 
of the ubiquitin chain that is optimal for proteasomal targeting of substrate proteins and 
modulates longevity19. 
Dietary restriction (DR) is defined by the reduction in caloric intake while 
maintaining essential nutrient requirements. The major transcription factors important for 
DR-dependent lifespan extension are PHA-4/FoxA and SKN-1/Nrf215. The CUL-4/DDB-1 
ubiquitin ligase together with WDR-23 has been shown to degrade SKN-1 and limits the 
lifespan of worms20. Similarly, Nrf2 is ubiquitylated by the Cul3-Keap1-E3 ligase in 
mammalian cells21. Another E3 ligase, WWP-1 and the E2 ubiquitin conjugating enzyme, 
UBC-18 have been shown to positively regulate the lifespan of DR worms in a PHA-4-
dependent manner. However, the direct substrate of WWP-1 is yet unknown22. DR may 
promote longevity by metabolic reprogramming towards increased protein degradation, 
thereby ameliorating the age-related impairment of both proteasomal and autophagic 
turnover.  
The hypoxia-inducible factor 1 (HIF-1), a highly conserved transcriptional regulator 
of hypoxic stress response, is also involved in regulation of lifespan23. The von Hippel 
Lindau (VHL) E3 ubiquitin ligase negatively regulates HIF-1 by promoting its 
polyubiquitylation and proteasomal turnover. Although the mechanism how HIF-1 
stabilization modulates the aging process is unclear, lifespan extension by the hypoxic 
pathway appears to be distinct from IIS and DR. 
 Ubiquitin’s impact on aging 
Since the first discovery of its role in aging, there is growing interest in understanding the 
mechanistic aspects and physiological relevance of ubiquitin modifications in lifespan 
regulation. Recent advances in proteomic approaches opened new avenues in identifying 
targets of ubiquitylation; however, comprehensive studies on age-related changes of the 
ubiquitin-modified proteome are still missing. It is commonly accepted that the 
progressive impairment of the UPS contributes to natural aging. An evolving paradigm of 
aging research is the mutual regulation of ubiquitin-dependent proteolysis and the aging 
process itself but many important questions are waiting to be addressed. For example, it 
is unclear how detrimental the decline in proteolytic capacity is for cellular maintenance. 
The progressive impairment of the UPS might cause a systemic loss of cellular 
homeostasis, not only disintegrating cellular function but also causing death of 
multicellular organisms. Moreover, a genetically defined shift in the global ubiquitylation 
pattern of the proteome might initiate age-specific response programs. Interestingly, a 
recent study in worms proposed that proteostasis collapse might be a programmed event 
that elevates the load of damaged proteins at an early time of life, possibly representing 
the first incident preceding aging24. In contrast, the specific degradation of key longevity 
regulators provides alternative explanations for the regulation of aging and longevity 
governed by ubiquitin. Thereby, the overall functional decline of the UPS might even 
potentiate the misregulation of important lifespan pathways. 
Accumulating evidence suggests that proteasomal degradation is not the only 
mechanism that links ubiquitylation to the aging process. A fascinating new field of 
research covering epigenetic regulation of longevity might involve monoubiquitylation of 
histone H2B25. Substrate ubiquitylation can provide a variety of modification signals that 
render the substrate for different fates. The regulation of H2B represents only the tip of 
the iceberg indicating that additional unconventional roles of ubiquitin in lifespan 
regulation remain to be discovered. Given the mutual link between ubiquitin-dependent 
pathways and longevity, in-depth understanding of age-related alterations of UPS 
function would undoubtedly provide new opportunities for therapeutic interventions in the 
aging process and age-related diseases. 
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FIGURE LEGENDS 
 
Figure 1 UPS activity orchestrates the aging process. The most extensively studied 
genetic program regulating stress tolerance and aging is the insulin/insulin-like growth 
factor 1 (IGF-1) signaling (IIS) pathway. Activation of the insulin/IGF-1 receptor (IR) 
initiates the phosphorylation of multiple downstream kinases (PI3K, AKT), which inhibit 
the nuclear accumulation of the FoxO and Nrf2 transcription factors. The indicated 
ubiquitin-dependent degradation pathways regulate the stability of multiple signaling 
components of the IIS. When insulin signaling is limited, FoxO and Nrf2 translocate to the 
nuclei and upregulate the expression of proteasomal subunits enhancing the proteolytic 
capacity of the 26S proteasome. In contrast, ROS production in mitochondria or 
aggregation of misfolded proteins in the cytosol reduces proteasomal function during 
aging. 
 
IR: Insulin/IGF-1 receptor; IRS: Insulin receptor substrate; PI3K: Phosphatidyl inositol 3-
kinase; PIP2: phosphatidylinositol-4,5- diphosphosphate; PIP3: phosphatidylinositol-
3,4,5-triphosphate; PTEN: Phosphatase and Tensin homolog; AKT: AKT kinase; FoxO: 
Forkhead box O transcription factor; Nrf2: nuclear factor, erythroid 2-like 2. 
 
  
 
